Hims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of ($0.07), versus ($0.16) reported last year. Revenue for the quarter came in at $41.47 million, versus $41.32 million reported last year.

“We closed out this important year for Hims & Hers on a high note, meeting or exceeding the expectations for 2020 performance in our roadshow this past fall, including 80% revenue growth year-over-year and improved gross margins,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “We also made smart investments that set us up well to drive future growth in 2021 as we work to create the new front door to the healthcare system.”

Mr. Dudum continued, “During the fourth quarter, with the 2020 election and a particularly unique holiday season as the backdrop, we saw advertising rates spike, so we took deliberate and careful steps to manage our expenses in the fourth quarter, which led to moderate quarter-over-quarter sales growth while still exceeding our full-year 2020 revenue plan. These dynamics have normalized in the first quarter and we are seeing improved opportunities to invest in growth. We’ve started 2021 off strong and are raising our full year forecast accordingly. This is an organization built on solid fundamentals and favorable business characteristics and I’m incredibly confident in our ability to deliver on our vision of helping more people with a wider range of conditions access great, affordable care.”

GUIDANCE:

Hims & Hers Health, Inc. sees Q1 2021 revenue of $48-50 million.

Hims & Hers Health, Inc. sees FY2021 revenue of $195-205 million.

Hims & Hers provides guidance based on current market conditions and expectations for revenue and Adjusted EBITDA, which is a non-GAAP financial measure.

For the first-quarter 2021, we expect:

• Revenue to be in the range of $48 million to $50 million.
• Adjusted EBITDA to be in the range of $(9.5) million to $(11.5) million.

For the full-year 2021, we expect:

• Revenue to be in the range of $195 million to $205 million.
• Adjusted EBITDA to be in the range of $(35) million to $(45) million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.